🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1830)
All (1830)
Buys (161)
Sells (1669)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
HALOZYME THERAPEUTICS, INC.
(HALO)
Caudill Cortney
— SVP, CHIEF OPERATING OFFICER
Mar 9, 2026
Sale
Shares
17,900
Price
$67.75
Total Value
$1.21M
Shares Held After
16,466
% of Holdings
52.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IRADIMED CORP
(IRMD)
Susi Roger E.
— Director
Mar 9, 2026
Sale
Shares
5,000
Price
$100.04
Total Value
$500.20K
Shares Held After
2,250,000
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
80
Price
$529.83
Total Value
$42.39K
Shares Held After
130
% of Holdings
38.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
678
Price
$528.85
Total Value
$358.56K
Shares Held After
210
% of Holdings
76.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
1,066
Price
$527.95
Total Value
$562.80K
Shares Held After
888
% of Holdings
54.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
240
Price
$526.60
Total Value
$126.38K
Shares Held After
1,954
% of Holdings
10.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
120
Price
$524.85
Total Value
$62.98K
Shares Held After
2,194
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
165
Price
$523.52
Total Value
$86.38K
Shares Held After
2,314
% of Holdings
6.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
335
Price
$522.02
Total Value
$174.88K
Shares Held After
2,479
% of Holdings
11.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
465
Price
$520.87
Total Value
$242.20K
Shares Held After
2,814
% of Holdings
14.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
520
Price
$519.99
Total Value
$270.40K
Shares Held After
3,279
% of Holdings
13.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
361
Price
$518.80
Total Value
$187.29K
Shares Held After
3,799
% of Holdings
8.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
319
Price
$517.83
Total Value
$165.19K
Shares Held After
4,160
% of Holdings
7.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
588
Price
$516.64
Total Value
$303.79K
Shares Held After
4,479
% of Holdings
11.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
678
Price
$515.81
Total Value
$349.72K
Shares Held After
5,067
% of Holdings
11.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
565
Price
$514.90
Total Value
$290.92K
Shares Held After
5,745
% of Holdings
9.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
676
Price
$513.65
Total Value
$347.23K
Shares Held After
6,310
% of Holdings
9.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
603
Price
$512.88
Total Value
$309.27K
Shares Held After
6,986
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
896
Price
$511.73
Total Value
$458.51K
Shares Held After
7,589
% of Holdings
10.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
701
Price
$510.81
Total Value
$358.07K
Shares Held After
8,485
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
244
Price
$509.49
Total Value
$124.32K
Shares Held After
9,186
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 9, 2026
Sale
Shares
200
Price
$500.05
Total Value
$100.01K
Shares Held After
9,430
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SUPERNUS PHARMACEUTICALS, INC.
(SUPN)
Mottola Frank
— SVP, Chief Tech. Ops. Officer
Mar 9, 2026
Sale
Shares
1,623
Price
$53.65
Total Value
$87.07K
Shares Held After
18,440
% of Holdings
8.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SUPERNUS PHARMACEUTICALS, INC.
(SUPN)
Horich William Todd
— SVP, Commercial Operations
Mar 9, 2026
Sale
Shares
4,438
Price
$54.00
Total Value
$239.65K
Shares Held After
4,439
% of Holdings
50.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ADMA BIOLOGICS, INC.
(ADMA)
Kestenberg-Messina Kaitlin M.
— COO and SVP, Compliance
Mar 9, 2026
Sale
Shares
10,096
Price
$15.63
Total Value
$157.80K
Shares Held After
466,600
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENET HEALTHCARE CORP
(THC)
Arnst Thomas W
— EVP, Chief Admin. Officer & GC
Mar 9, 2026
Sale
Shares
3,286
Price
$239.46
Total Value
$786.87K
Shares Held After
12
% of Holdings
99.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENET HEALTHCARE CORP
(THC)
Arnst Thomas W
— EVP, Chief Admin. Officer & GC
Mar 9, 2026
Sale
Shares
4,714
Price
$238.42
Total Value
$1.12M
Shares Held After
3,298
% of Holdings
58.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Mar 9, 2026
Sale
Shares
30,941
Price
$14.79
Total Value
$457.62K
Shares Held After
647,809
% of Holdings
4.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KalVista Pharmaceuticals, Inc.
(KALV)
Palleiko Benjamin L
— Director
Mar 9, 2026
Sale
Shares
6,693
Price
$16.08
Total Value
$107.63K
Shares Held After
451,815
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Boniface John J.
— Chief Scientific Officer
Mar 9, 2026
Sale
Shares
3,038
Price
$1.96
Total Value
$5.95K
Shares Held After
147,359
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Aerts Austin
— Chief Financial Officer
Mar 9, 2026
Sale
Shares
674
Price
$1.96
Total Value
$1.32K
Shares Held After
271,540
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Jackson Benjamin
— General Counsel
Mar 9, 2026
Sale
Shares
3,119
Price
$1.96
Total Value
$6.11K
Shares Held After
115,747
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Harrison Robert Gardner
— Chief Information Officer
Mar 9, 2026
Sale
Shares
3,360
Price
$1.96
Total Value
$6.59K
Shares Held After
77,428
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Kearney Paul
— Chief Data Officer
Mar 9, 2026
Sale
Shares
2,026
Price
$1.96
Total Value
$3.97K
Shares Held After
165,357
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alphatec Holdings, Inc.
(ATEC)
Hunsaker Craig E
— EVP, PEOPLE & CULTURE
Mar 9, 2026
Sale
Shares
82,765
Price
$12.45
Total Value
$1.03M
Shares Held After
1,726,209
% of Holdings
4.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Blum Robert I
— Director
Mar 9, 2026
Sale
Shares
7,931
Price
$60.72
Total Value
$481.57K
Shares Held After
391,673
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Malik Fady Ibraham
— EVP Research & Development
Mar 9, 2026
Sale
Shares
2,907
Price
$60.72
Total Value
$176.51K
Shares Held After
138,629
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Callos Andrew
— EVP, Chief Commercial Officer
Mar 9, 2026
Sale
Shares
2,582
Price
$60.72
Total Value
$156.78K
Shares Held After
47,858
% of Holdings
5.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ANI PHARMACEUTICALS INC
(ANIP)
Davis Krista
— SVP, CHIEF HR OFFICER
Mar 9, 2026
Sale
Shares
5,087
Price
$74.13
Total Value
$377.10K
Shares Held After
51,946
% of Holdings
8.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zai Lab Ltd
(ZLAB)
Du Ying
— Director
Mar 9, 2026
Sale
Shares
50,000
Price
$19.03
Total Value
$951.47K
Shares Held After
964,161
% of Holdings
4.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ANI PHARMACEUTICALS INC
(ANIP)
Mutz Christopher
— HEAD OF RARE DISEASE
Mar 9, 2026
Sale
Shares
3,602
Price
$74.18
Total Value
$267.20K
Shares Held After
94,471
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mountcastle David
— EVP & Chief Financial Officer
Mar 9, 2026
Sale
Shares
5,829
Price
$22.84
Total Value
$133.13K
Shares Held After
161,903
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Fargis Edward C
— EVP & General Counsel
Mar 9, 2026
Sale
Shares
4,949
Price
$22.84
Total Value
$113.04K
Shares Held After
83,711
% of Holdings
5.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mehrotra Parth
— Director
Mar 9, 2026
Sale
Shares
18,865
Price
$22.84
Total Value
$430.88K
Shares Held After
343,795
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mehrotra Parth
— Director
Mar 9, 2026
Sale
Shares
1,219
Price
$23.37
Total Value
$28.49K
Shares Held After
362,660
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mehrotra Parth
— Director
Mar 9, 2026
Sale
Shares
21,915
Price
$22.84
Total Value
$500.54K
Shares Held After
363,879
% of Holdings
5.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INTUITIVE SURGICAL INC
(ISRG)
Brosius Mark
— SVP & Chief Mfg and Supply Cha
Mar 9, 2026
Sale
Shares
645
Price
$485.01
Total Value
$312.83K
Shares Held After
1,613
% of Holdings
28.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Fay Edmund
— Sr. Vice Pres. and Treasurer
Mar 9, 2026
Sale
Shares
11,937
Price
$107.00
Total Value
$1.28M
Shares Held After
89,325
% of Holdings
11.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DENTSPLY SIRONA Inc.
(XRAY)
Forbes James D
— Director
Mar 9, 2026
Purchase
Shares
5,000
Price
$12.48
Total Value
$62.40K
Shares Held After
10,000
% of Holdings
50.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DENTSPLY SIRONA Inc.
(XRAY)
LUCIER GREGORY T
— Director
Mar 9, 2026
Purchase
Shares
15,000
Price
$12.45
Total Value
$186.68K
Shares Held After
65,000
% of Holdings
23.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 751–800 of 1830 transactions (page 16 of 37)
Version: v26.3.28